136 Columbia Way Surplus

The County of Tuolumne is soliciting proposals under solicitation GEN-2025-0118 for the development of 136 Columbia Way Surplus property, with the intent to leverage opioid settlement funds for community-based behavioral health initiatives. The project must comply with the California Surplus Land Act exemption under Government Code Section 54221(f)(1)(A), and any resulting development must adhere to deed restrictions, County monitoring obligations, and Opioid Settlement Funding conditions, including review and approval by the California Department of Housing and Community Development. Proposals will be evaluated based on project feasibility, affordability for low-income populations, capacity to deliver integrated supportive services for individuals with substance use disorders, and long-term financial sustainability, with a mandatory requirement that at least 50% of funds be allocated to High Impact Abatement Activities such as expanding SUD treatment infrastructure, providing naloxone, diverting individuals from the justice system into care, and targeting interventions toward vulnerable youth and communities of color. All expenditures must align with Exhibit E of the National Opioid Settlement Agreements and comply with California State-Subdivision Agreements, which prohibit spending on law enforcement equipment, non-FDA-approved medications, or unrelated infrastructure. The County will conduct good-faith negotiations with the selected proposer, and award is contingent on full compliance with financial accountability standards, including adherence to GAAP, tracking of funding sources, and annual reporting to the Department of Health Care Services. The solicitation is open through June 2, 2026, with submissions required through an online portal, and the contracting office is located in Sonora, California, under the Health and Human Services Agency. No formal FAR clauses, contract pricing, packaging requirements, or commercial offeror certifications are included, as the solicitation targets public entities and focuses on compliance with public health funding mandates rather than commercial procurement norms.